-
1
-
-
84954400636
-
Cancer statistics, 2016
-
[1] Siegel, R.L., Miller, K.D., Jemal, A., Cancer statistics, 2016. CA: Cancer J. Clin. 66:1 (2016), 7–30.
-
(2016)
CA: Cancer J. Clin.
, vol.66
, Issue.1
, pp. 7-30
-
-
Siegel, R.L.1
Miller, K.D.2
Jemal, A.3
-
2
-
-
80054113553
-
Guidelines of care for the management of primary cutaneous melanoma. American Academy of Dermatology
-
[2] Bichakjian, C.K., Halpern, A.C., Johnson, T.M., Foote Hood, A., Grichnik, J.M., Swetter, S.M., Tsao, H., Barbosa, V.H., Chuang, T.Y., Duvic, M., Ho, V.C., Sober, A.J., Beutner, K.R., Bhushan, R., Smith Begolka, W., Guidelines of care for the management of primary cutaneous melanoma. American Academy of Dermatology. J. Am. Acad. Dermatol. 65:5 (2011), 1032–1047.
-
(2011)
J. Am. Acad. Dermatol.
, vol.65
, Issue.5
, pp. 1032-1047
-
-
Bichakjian, C.K.1
Halpern, A.C.2
Johnson, T.M.3
Foote Hood, A.4
Grichnik, J.M.5
Swetter, S.M.6
Tsao, H.7
Barbosa, V.H.8
Chuang, T.Y.9
Duvic, M.10
Ho, V.C.11
Sober, A.J.12
Beutner, K.R.13
Bhushan, R.14
Smith Begolka, W.15
-
3
-
-
4344656396
-
Management of cutaneous melanoma
-
[3] Tsao, H., Atkins, M.B., Sober, A.J., Management of cutaneous melanoma. N. Engl. J. Med. 351:10 (2004), 998–1012.
-
(2004)
N. Engl. J. Med.
, vol.351
, Issue.10
, pp. 998-1012
-
-
Tsao, H.1
Atkins, M.B.2
Sober, A.J.3
-
4
-
-
84860382327
-
The role of BRAF V600 mutation in melanoma
-
85–85
-
[4] Ascierto, P.A., Kirkwood, J.M., Grob, J.-J., Simeone, E., Grimaldi, A.M., Maio, M., Palmieri, G., Testori, A., Marincola, F.M., Mozzillo, N., The role of BRAF V600 mutation in melanoma. J. Transl. Med., 10, 2012 85–85.
-
(2012)
J. Transl. Med.
, vol.10
-
-
Ascierto, P.A.1
Kirkwood, J.M.2
Grob, J.-J.3
Simeone, E.4
Grimaldi, A.M.5
Maio, M.6
Palmieri, G.7
Testori, A.8
Marincola, F.M.9
Mozzillo, N.10
-
5
-
-
34248193424
-
Mutant V600E BRAF increases hypoxia inducible factor-1alpha expression in melanoma
-
[5] Kumar, S.M., Yu, H., Edwards, R., Chen, L., Kazianis, S., Brafford, P., Acs, G., Herlyn, M., Xu, X., Mutant V600E BRAF increases hypoxia inducible factor-1alpha expression in melanoma. Cancer Res. 67:7 (2007), 3177–3184.
-
(2007)
Cancer Res.
, vol.67
, Issue.7
, pp. 3177-3184
-
-
Kumar, S.M.1
Yu, H.2
Edwards, R.3
Chen, L.4
Kazianis, S.5
Brafford, P.6
Acs, G.7
Herlyn, M.8
Xu, X.9
-
6
-
-
84885127137
-
Putative role of HIF transcriptional activity in melanocytes and melanoma biology
-
[6] Zbytek, B., Peacock, D.L., Seagroves, T.N., Slominski, A., Putative role of HIF transcriptional activity in melanocytes and melanoma biology. Dermato-endocrinology 5:2 (2013), 239–251.
-
(2013)
Dermato-endocrinology
, vol.5
, Issue.2
, pp. 239-251
-
-
Zbytek, B.1
Peacock, D.L.2
Seagroves, T.N.3
Slominski, A.4
-
7
-
-
80052682410
-
Immunohistochemical expression of VEGF, HIF1-a, and PlGF in malignant melanomas and dysplastic nevi
-
[7] Konstantina, A., Lazaris, A.C., Ioannidis, E., Liossi, A., Aroni, K., Immunohistochemical expression of VEGF, HIF1-a, and PlGF in malignant melanomas and dysplastic nevi. Melanoma Res. 21:5 (2011), 389–394.
-
(2011)
Melanoma Res.
, vol.21
, Issue.5
, pp. 389-394
-
-
Konstantina, A.1
Lazaris, A.C.2
Ioannidis, E.3
Liossi, A.4
Aroni, K.5
-
8
-
-
76349095132
-
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
-
[8] Semenza, G.L., Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 29:5 (2010), 625–634.
-
(2010)
Oncogene
, vol.29
, Issue.5
, pp. 625-634
-
-
Semenza, G.L.1
-
9
-
-
77950906905
-
Investigating the dependence of the hypoxia-inducible factor hydroxylases (factor inhibiting HIF and prolyl hydroxylase domain 2) on ascorbate and other reducing agents
-
[9] Flashman, E., Davies, S.L., Yeoh, K.K., Schofield, C.J., Investigating the dependence of the hypoxia-inducible factor hydroxylases (factor inhibiting HIF and prolyl hydroxylase domain 2) on ascorbate and other reducing agents. Biochem. J. 427:1 (2010), 135–142.
-
(2010)
Biochem. J.
, vol.427
, Issue.1
, pp. 135-142
-
-
Flashman, E.1
Davies, S.L.2
Yeoh, K.K.3
Schofield, C.J.4
-
10
-
-
84915763059
-
Ascorbate as a co-factor for fe- and 2-oxoglutarate dependent dioxygenases: physiological activity in tumor growth and progression
-
[10] Kuiper, C., Vissers, M.C., Ascorbate as a co-factor for fe- and 2-oxoglutarate dependent dioxygenases: physiological activity in tumor growth and progression. Front. Oncol., 4, 2014, 359.
-
(2014)
Front. Oncol.
, vol.4
, pp. 359
-
-
Kuiper, C.1
Vissers, M.C.2
-
11
-
-
84866613772
-
Ascorbic acid: chemistry, biology and the treatment of cancer
-
[11] Du, J., Cullen, J.J., Buettner, G.R., Ascorbic acid: chemistry, biology and the treatment of cancer. Biochim. Biophys. Acta (BBA) – Rev. Cancer 1826:2 (2012), 443–457.
-
(2012)
Biochim. Biophys. Acta (BBA) – Rev. Cancer
, vol.1826
, Issue.2
, pp. 443-457
-
-
Du, J.1
Cullen, J.J.2
Buettner, G.R.3
-
12
-
-
84894531953
-
Decreased plasma ascorbate levels in stage IV melanoma patients
-
[12] Schleich, T., Rodemeister, S., Venturelli, S., Sinnberg, T., Garbe, C., Busch, C., Decreased plasma ascorbate levels in stage IV melanoma patients. Metab. Nutr. Oncol. 1:01 (2013), e2–e6.
-
(2013)
Metab. Nutr. Oncol.
, vol.1
, Issue.1
, pp. e2-e6
-
-
Schleich, T.1
Rodemeister, S.2
Venturelli, S.3
Sinnberg, T.4
Garbe, C.5
Busch, C.6
-
13
-
-
0032580628
-
Scurvy in patients with cancer
-
[13] Fain, O., Mathieu, E., Thomas, M., Scurvy in patients with cancer. BMJ (Clin. Res.) 316:7145 (1998), 1661–1662.
-
(1998)
BMJ (Clin. Res.)
, vol.316
, Issue.7145
, pp. 1661-1662
-
-
Fain, O.1
Mathieu, E.2
Thomas, M.3
-
14
-
-
13444301515
-
Vitamin C deficiency in cancer patients
-
[14] Mayland, C.R., Bennett, M.I., Allan, K., Vitamin C deficiency in cancer patients. Palliat. Med. 19:1 (2005), 17–20.
-
(2005)
Palliat. Med.
, vol.19
, Issue.1
, pp. 17-20
-
-
Mayland, C.R.1
Bennett, M.I.2
Allan, K.3
-
15
-
-
84881427604
-
Clinical experience with intravenous administration of ascorbic acid: achievable levels in blood for different states of inflammation and disease in cancer patients
-
[15] Mikirova, N., Casciari, J., Riordan, N., Hunninghake, R., Clinical experience with intravenous administration of ascorbic acid: achievable levels in blood for different states of inflammation and disease in cancer patients. J. Transl. Med., 11, 2013, 191.
-
(2013)
J. Transl. Med.
, vol.11
, pp. 191
-
-
Mikirova, N.1
Casciari, J.2
Riordan, N.3
Hunninghake, R.4
-
16
-
-
84954549897
-
Ascorbic acid serum levels are reduced in patients with hematological malignancies
-
[16] Huijskens, M.J., Wodzig, W.K., Walczak, M., Germeraad, W.T., Bos, G.M., Ascorbic acid serum levels are reduced in patients with hematological malignancies. Results Immunol. 6 (2016), 8–10.
-
(2016)
Results Immunol.
, vol.6
, pp. 8-10
-
-
Huijskens, M.J.1
Wodzig, W.K.2
Walczak, M.3
Germeraad, W.T.4
Bos, G.M.5
-
17
-
-
77955037416
-
Low ascorbate levels are associated with increased hypoxia-inducible factor-1 activity and an aggressive tumor phenotype in endometrial cancer
-
[17] Kuiper, C., Molenaar, I.G., Dachs, G.U., Currie, M.J., Sykes, P.H., Vissers, M.C., Low ascorbate levels are associated with increased hypoxia-inducible factor-1 activity and an aggressive tumor phenotype in endometrial cancer. Cancer Res. 70:14 (2010), 5749–5758.
-
(2010)
Cancer Res.
, vol.70
, Issue.14
, pp. 5749-5758
-
-
Kuiper, C.1
Molenaar, I.G.2
Dachs, G.U.3
Currie, M.J.4
Sykes, P.H.5
Vissers, M.C.6
-
18
-
-
84896737068
-
Increased tumor ascorbate is associated with extended disease-Free survival and decreased hypoxia-Inducible factor-1 activation in human colorectal cancer
-
[18] Kuiper, C., Dachs, G.U., Munn, D., Currie, M.J., Robinson, B.A., Pearson, J.F., Vissers, M.C., Increased tumor ascorbate is associated with extended disease-Free survival and decreased hypoxia-Inducible factor-1 activation in human colorectal cancer. Front. Oncol., 4, 2014, 10.
-
(2014)
Front. Oncol.
, vol.4
, pp. 10
-
-
Kuiper, C.1
Dachs, G.U.2
Munn, D.3
Currie, M.J.4
Robinson, B.A.5
Pearson, J.F.6
Vissers, M.C.7
-
19
-
-
84946400605
-
Ascorbic acid and ascorbate-2-phosphate decrease HIF activity and malignant properties of human melanoma cells
-
[19] Miles, S.L., Fischer, A.P., Joshi, S.J., Niles, R.M., Ascorbic acid and ascorbate-2-phosphate decrease HIF activity and malignant properties of human melanoma cells. BMC Cancer, 15(1), 2015, 867.
-
(2015)
BMC Cancer
, vol.15
, Issue.1
, pp. 867
-
-
Miles, S.L.1
Fischer, A.P.2
Joshi, S.J.3
Niles, R.M.4
-
20
-
-
75649129140
-
Expression and function of hypoxia inducible factor-1 alpha in human melanoma under non-hypoxic conditions
-
[20] Mills, C.N., Joshi, S.S., Niles, R.M., Expression and function of hypoxia inducible factor-1 alpha in human melanoma under non-hypoxic conditions. Mol. Cancer, 8, 2009, 104.
-
(2009)
Mol. Cancer
, vol.8
, pp. 104
-
-
Mills, C.N.1
Joshi, S.S.2
Niles, R.M.3
-
21
-
-
84990310417
-
Restoring physiological levels of ascorbate slows tumor growth and moderates HIF-1 pathway activity in Gulo(-/-) mice
-
[21] Campbell, E.J., Vissers, M.C., Bozonet, S., Dyer, A., Robinson, B.A., Dachs, G.U., Restoring physiological levels of ascorbate slows tumor growth and moderates HIF-1 pathway activity in Gulo(-/-) mice. Cancer Med. 4 (2015), 303–314.
-
(2015)
Cancer Med.
, vol.4
, pp. 303-314
-
-
Campbell, E.J.1
Vissers, M.C.2
Bozonet, S.3
Dyer, A.4
Robinson, B.A.5
Dachs, G.U.6
-
22
-
-
84855541345
-
Ascorbate depletion increases growth and metastasis of melanoma cells in vitamin C deficient mice
-
[22] Cha, J., Roomi, M.W., Ivanov, V., Kalinovsky, T., Niedzwiecki, A., Rath, M., Ascorbate depletion increases growth and metastasis of melanoma cells in vitamin C deficient mice. Exp. Oncol. 33:4 (2011), 226–230.
-
(2011)
Exp. Oncol.
, vol.33
, Issue.4
, pp. 226-230
-
-
Cha, J.1
Roomi, M.W.2
Ivanov, V.3
Kalinovsky, T.4
Niedzwiecki, A.5
Rath, M.6
-
23
-
-
84873683033
-
Ascorbate supplementation inhibits growth and metastasis of B16FO melanoma and 4T1 breast cancer cells in vitamin C-deficient mice
-
[23] Cha, J., Roomi, M.W., Ivanov, V., Kalinovsky, T., Niedzwiecki, A., Rath, M., Ascorbate supplementation inhibits growth and metastasis of B16FO melanoma and 4T1 breast cancer cells in vitamin C-deficient mice. Int. J. Oncol. 42:1 (2013), 55–64.
-
(2013)
Int. J. Oncol.
, vol.42
, Issue.1
, pp. 55-64
-
-
Cha, J.1
Roomi, M.W.2
Ivanov, V.3
Kalinovsky, T.4
Niedzwiecki, A.5
Rath, M.6
-
24
-
-
0036006650
-
Very low vitamin C activity of orally administered l-Dehydroascorbic acid
-
[24] Ogiri, Y., Sun, F., Hayami, S., Fujimura, A., Yamamoto, K., Yaita, M., Kojo, S., Very low vitamin C activity of orally administered l-Dehydroascorbic acid. J. Agric. Food Chem. 50:1 (2002), 227–229.
-
(2002)
J. Agric. Food Chem.
, vol.50
, Issue.1
, pp. 227-229
-
-
Ogiri, Y.1
Sun, F.2
Hayami, S.3
Fujimura, A.4
Yamamoto, K.5
Yaita, M.6
Kojo, S.7
-
25
-
-
0022467648
-
Antiscorbutic effect of dehydro-L-Ascorbic acid in vitamin C-Deficient Guinea pigs
-
[25] Otsuka, M., Kurata, T., Arakawa, N., Antiscorbutic effect of dehydro-L-Ascorbic acid in vitamin C-Deficient Guinea pigs. J. Nutr. Sci. Vitaminol. (Tokyo) 32:2 (1986), 183–190.
-
(1986)
J. Nutr. Sci. Vitaminol. (Tokyo)
, vol.32
, Issue.2
, pp. 183-190
-
-
Otsuka, M.1
Kurata, T.2
Arakawa, N.3
-
26
-
-
84947767028
-
l-dehydroascorbic acid can substitute l-ascorbic acid as dietary vitamin C source in guinea pigs
-
[26] Frikke-Schmidt, H., Tveden-Nyborg, P., Lykkesfeldt, J., l-dehydroascorbic acid can substitute l-ascorbic acid as dietary vitamin C source in guinea pigs. Redox Biol. 7 (2016), 8–13.
-
(2016)
Redox Biol.
, vol.7
, pp. 8-13
-
-
Frikke-Schmidt, H.1
Tveden-Nyborg, P.2
Lykkesfeldt, J.3
-
27
-
-
0001228128
-
Utilization of dehydroascorbic acid by human subjects
-
[27] Todhunter, E.N., Mc, M.T., Ehmke, D.A., Utilization of dehydroascorbic acid by human subjects. J. Nutr. 42:2 (1950), 297–308.
-
(1950)
J. Nutr.
, vol.42
, Issue.2
, pp. 297-308
-
-
Todhunter, E.N.1
Mc, M.T.2
Ehmke, D.A.3
-
28
-
-
84883787092
-
Expression and/or activity of the SVCT2 ascorbate transporter may be decreased in many aggressive cancers, suggesting potential utility for sodium bicarbonate and dehydroascorbic acid in cancer therapy
-
[28] McCarty, M.F., Expression and/or activity of the SVCT2 ascorbate transporter may be decreased in many aggressive cancers, suggesting potential utility for sodium bicarbonate and dehydroascorbic acid in cancer therapy. Med. Hypotheses 81:4 (2013), 664–670.
-
(2013)
Med. Hypotheses
, vol.81
, Issue.4
, pp. 664-670
-
-
McCarty, M.F.1
-
29
-
-
84930277289
-
Cancer metabolism and the Warburg effect: the role of HIF-1 and PI3K
-
[29] Courtnay, R., Ngo, D.C., Malik, N., Ververis, K., Tortorella, S.M., Karagiannis, T.C., Cancer metabolism and the Warburg effect: the role of HIF-1 and PI3K. Mol. Biol. Rep. 42:4 (2015), 841–851.
-
(2015)
Mol. Biol. Rep.
, vol.42
, Issue.4
, pp. 841-851
-
-
Courtnay, R.1
Ngo, D.C.2
Malik, N.3
Ververis, K.4
Tortorella, S.M.5
Karagiannis, T.C.6
-
30
-
-
33845717875
-
Vitamin C. Biosynthesis, recycling and degradation in mammals
-
[30] Linster, C.L., Van Schaftingen, E., Vitamin C. Biosynthesis, recycling and degradation in mammals. FEBS J. 274:1 (2007), 1–22.
-
(2007)
FEBS J.
, vol.274
, Issue.1
, pp. 1-22
-
-
Linster, C.L.1
Van Schaftingen, E.2
-
31
-
-
34247215182
-
A simple and sensitive assay for ascorbate using a plate reader
-
[31] Vislisel, J.M., Schafer, F.Q., Buettner, G.R., A simple and sensitive assay for ascorbate using a plate reader. Anal. Biochem. 365:1 (2007), 31–39.
-
(2007)
Anal. Biochem.
, vol.365
, Issue.1
, pp. 31-39
-
-
Vislisel, J.M.1
Schafer, F.Q.2
Buettner, G.R.3
-
32
-
-
84941248245
-
Three-dimensional (3D) tumor spheroid invasion assay
-
[32] Vinci, M., Box, C., Eccles, S.A., Three-dimensional (3D) tumor spheroid invasion assay. J. Vis. Exp. JoVE, 99, 2015, e52686.
-
(2015)
J. Vis. Exp. JoVE
, vol.99
, pp. e52686
-
-
Vinci, M.1
Box, C.2
Eccles, S.A.3
-
33
-
-
0023021512
-
Partial identity of the 2-oxoglutarate and ascorbate binding sites of prolyl 4-hydroxylase
-
[33] Majamaa, K., Gunzler, V., Hanauske-Abel, H.M., Myllyla, R., Kivirikko, K.I., Partial identity of the 2-oxoglutarate and ascorbate binding sites of prolyl 4-hydroxylase. J. Biol. Chem. 261:17 (1986), 7819–7823.
-
(1986)
J. Biol. Chem.
, vol.261
, Issue.17
, pp. 7819-7823
-
-
Majamaa, K.1
Gunzler, V.2
Hanauske-Abel, H.M.3
Myllyla, R.4
Kivirikko, K.I.5
-
34
-
-
71749114853
-
Keeping the intracellular vitamin C at a physiologically relevant level in endothelial cell culture
-
[34] Frikke-Schmidt, H., Lykkesfeldt, J., Keeping the intracellular vitamin C at a physiologically relevant level in endothelial cell culture. Anal. Biochem. 397:1 (2010), 135–137.
-
(2010)
Anal. Biochem.
, vol.397
, Issue.1
, pp. 135-137
-
-
Frikke-Schmidt, H.1
Lykkesfeldt, J.2
-
35
-
-
84890461711
-
Myths, artifacts, and fatal flaws: identifying limitations and opportunities in vitamin C research
-
[35] Michels, A.J., Frei, B., Myths, artifacts, and fatal flaws: identifying limitations and opportunities in vitamin C research. Nutrients 5:12 (2013), 5161–5192.
-
(2013)
Nutrients
, vol.5
, Issue.12
, pp. 5161-5192
-
-
Michels, A.J.1
Frei, B.2
-
36
-
-
77954620240
-
Cellular pathways for transport and efflux of ascorbate and dehydroascorbate
-
[36] Corti, A., Casini, A.F., Pompella, A., Cellular pathways for transport and efflux of ascorbate and dehydroascorbate. Arch. Biochem. Biophys. 500:2 (2010), 107–115.
-
(2010)
Arch. Biochem. Biophys.
, vol.500
, Issue.2
, pp. 107-115
-
-
Corti, A.1
Casini, A.F.2
Pompella, A.3
-
37
-
-
84880802348
-
Regulation of vitamin C homeostasis during deficiency
-
[37] Lindblad, M., Tveden-Nyborg, P., Lykkesfeldt, J., Regulation of vitamin C homeostasis during deficiency. Nutrients 5:8 (2013), 2860–2879.
-
(2013)
Nutrients
, vol.5
, Issue.8
, pp. 2860-2879
-
-
Lindblad, M.1
Tveden-Nyborg, P.2
Lykkesfeldt, J.3
-
38
-
-
81355134502
-
The SLC23 family of ascorbate transporters: ensuring that you get and keep your daily dose of vitamin C
-
[38] May, J.M., The SLC23 family of ascorbate transporters: ensuring that you get and keep your daily dose of vitamin C. Br. J. Pharmacol. 164:7 (2011), 1793–1801.
-
(2011)
Br. J. Pharmacol.
, vol.164
, Issue.7
, pp. 1793-1801
-
-
May, J.M.1
-
39
-
-
0035010528
-
Vitamin C transport systems of mammalian cells
-
[39] Liang, W.J., Johnson, D., Jarvis, S.M., Vitamin C transport systems of mammalian cells. Mol. Membr. Biol. 18:1 (2001), 87–95.
-
(2001)
Mol. Membr. Biol.
, vol.18
, Issue.1
, pp. 87-95
-
-
Liang, W.J.1
Johnson, D.2
Jarvis, S.M.3
-
40
-
-
0030773936
-
Enhanced protection against peroxidation-induced mortality of aortic endothelial cells by ascorbic acid-2-O-phosphate abundantly accumulated in the cell as the dephosphorylated form
-
[40] Fujiwara, M., Nagao, N., Monden, K., Misumi, M., Kageyama, K., Yamamoto, K., Miwa, N., Enhanced protection against peroxidation-induced mortality of aortic endothelial cells by ascorbic acid-2-O-phosphate abundantly accumulated in the cell as the dephosphorylated form. Free Radic. Res. 27:1 (1997), 97–104.
-
(1997)
Free Radic. Res.
, vol.27
, Issue.1
, pp. 97-104
-
-
Fujiwara, M.1
Nagao, N.2
Monden, K.3
Misumi, M.4
Kageyama, K.5
Yamamoto, K.6
Miwa, N.7
-
41
-
-
0035083741
-
Monitoring of ascorbate at a constant rate in cell culture: effect on cell growth, In vitro cellular & developmental biology
-
[41] Chepda, T., Cadau, M., Girin, P., Frey, J., Chamson, A., Monitoring of ascorbate at a constant rate in cell culture: effect on cell growth, In vitro cellular & developmental biology. Animal 37:1 (2001), 26–30.
-
(2001)
Animal
, vol.37
, Issue.1
, pp. 26-30
-
-
Chepda, T.1
Cadau, M.2
Girin, P.3
Frey, J.4
Chamson, A.5
-
42
-
-
0030983467
-
Increased facilitated transport of dehydroascorbic acid without changes in sodium-dependent ascorbate transport in human melanoma cells
-
[42] Spielholz, C., Golde, D.W., Houghton, A.N., Nualart, F., Vera, J.C., Increased facilitated transport of dehydroascorbic acid without changes in sodium-dependent ascorbate transport in human melanoma cells. Cancer Res. 57:12 (1997), 2529–2537.
-
(1997)
Cancer Res.
, vol.57
, Issue.12
, pp. 2529-2537
-
-
Spielholz, C.1
Golde, D.W.2
Houghton, A.N.3
Nualart, F.4
Vera, J.C.5
-
43
-
-
84874886049
-
Acidity generated by the tumor microenvironment drives local invasion
-
[43] Estrella, V., Chen, T., Lloyd, M., Wojtkowiak, J., Cornnell, H.H., Ibrahim-Hashim, A., Bailey, K., Balagurunathan, Y., Rothberg, J.M., Sloane, B.F., Johnson, J., Gatenby, R.A., Gillies, R.J., Acidity generated by the tumor microenvironment drives local invasion. Cancer Res. 73:5 (2013), 1524–1535.
-
(2013)
Cancer Res.
, vol.73
, Issue.5
, pp. 1524-1535
-
-
Estrella, V.1
Chen, T.2
Lloyd, M.3
Wojtkowiak, J.4
Cornnell, H.H.5
Ibrahim-Hashim, A.6
Bailey, K.7
Balagurunathan, Y.8
Rothberg, J.M.9
Sloane, B.F.10
Johnson, J.11
Gatenby, R.A.12
Gillies, R.J.13
-
44
-
-
77949486311
-
Constitutive HIF-1 activity in malignant melanoma
-
(Oxford, England: 1990)
-
[44] Kuphal, S., Winklmeier, A., Warnecke, C., Bosserhoff, A.K., Constitutive HIF-1 activity in malignant melanoma. Eur. J. Cancer 46:6 (2010), 1159–1169 (Oxford, England: 1990).
-
(2010)
Eur. J. Cancer
, vol.46
, Issue.6
, pp. 1159-1169
-
-
Kuphal, S.1
Winklmeier, A.2
Warnecke, C.3
Bosserhoff, A.K.4
-
45
-
-
4944246547
-
The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis
-
[45] Greijer, A.E., van der Wall, E., The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis. J. Clin. Pathol. 57:10 (2004), 1009–1014.
-
(2004)
J. Clin. Pathol.
, vol.57
, Issue.10
, pp. 1009-1014
-
-
Greijer, A.E.1
van der Wall, E.2
-
46
-
-
84934987255
-
Hypoxia-inducible factor-1 in physiological and pathophysiological angiogenesis: applications and therapies
-
[46] Zimna, A., Kurpisz, M., Hypoxia-inducible factor-1 in physiological and pathophysiological angiogenesis: applications and therapies. BioMed. Res. Int., 2015, 2015, 549412.
-
(2015)
BioMed. Res. Int.
, vol.2015
, pp. 549412
-
-
Zimna, A.1
Kurpisz, M.2
-
47
-
-
78650373860
-
Hypoxia and hypoxia-inducible factors: master regulators of metastasis
-
[47] Lu, X., Kang, Y., Hypoxia and hypoxia-inducible factors: master regulators of metastasis. Clin. Cancer Res.: Official J. Am. Assoc. Cancer Res. 16:24 (2010), 5928–5935.
-
(2010)
Clin. Cancer Res.: Official J. Am. Assoc. Cancer Res.
, vol.16
, Issue.24
, pp. 5928-5935
-
-
Lu, X.1
Kang, Y.2
-
48
-
-
79952284127
-
Hallmarks of cancer: the next generation
-
[48] Hanahan, D., Weinberg, R.A., Hallmarks of cancer: the next generation. Cell 144:5 (2011), 646–674.
-
(2011)
Cell
, vol.144
, Issue.5
, pp. 646-674
-
-
Hanahan, D.1
Weinberg, R.A.2
-
49
-
-
0037063311
-
The physiological role of dehydroascorbic acid
-
[49] Wilson, J.X., The physiological role of dehydroascorbic acid. FEBS Lett. 527:1–3 (2002), 5–9.
-
(2002)
FEBS Lett.
, vol.527
, Issue.1-3
, pp. 5-9
-
-
Wilson, J.X.1
-
50
-
-
84884213220
-
SVCT-2 in breast cancer acts as an indicator for L-ascorbate treatment
-
[50] Hong, S.W., Lee, S.H., Moon, J.H., Hwang, J.J., Kim, D.E., Ko, E., Kim, H.S., Cho, I.J., Kang, J.S., Kim, D.J., Kim, J.E., Shin, J.S., Jung, D.J., Jeong, Y.J., Cho, B.J., Kim, T.W., Lee, J.S., Kang, J.S., Hwang, Y.I., Noh, D.Y., Jin, D.H., Lee, W.J., SVCT-2 in breast cancer acts as an indicator for L-ascorbate treatment. Oncogene 32:12 (2013), 1508–1517.
-
(2013)
Oncogene
, vol.32
, Issue.12
, pp. 1508-1517
-
-
Hong, S.W.1
Lee, S.H.2
Moon, J.H.3
Hwang, J.J.4
Kim, D.E.5
Ko, E.6
Kim, H.S.7
Cho, I.J.8
Kang, J.S.9
Kim, D.J.10
Kim, J.E.11
Shin, J.S.12
Jung, D.J.13
Jeong, Y.J.14
Cho, B.J.15
Kim, T.W.16
Lee, J.S.17
Kang, J.S.18
Hwang, Y.I.19
Noh, D.Y.20
Jin, D.H.21
Lee, W.J.22
more..
-
51
-
-
84898010568
-
Mitochondrial ascorbic acid transport is mediated by a low-affinity form of the sodium-coupled ascorbic acid transporter-2
-
[51] Munoz-Montesino, C., Roa, F.J., Pena, E., Gonzalez, M., Sotomayor, K., Inostroza, E., Munoz, C.A., Gonzalez, I., Maldonado, M., Soliz, C., Reyes, A.M., Vera, J.C., Rivas, C.I., Mitochondrial ascorbic acid transport is mediated by a low-affinity form of the sodium-coupled ascorbic acid transporter-2. Free Radic. Biol. Med. 70 (2014), 241–254.
-
(2014)
Free Radic. Biol. Med.
, vol.70
, pp. 241-254
-
-
Munoz-Montesino, C.1
Roa, F.J.2
Pena, E.3
Gonzalez, M.4
Sotomayor, K.5
Inostroza, E.6
Munoz, C.A.7
Gonzalez, I.8
Maldonado, M.9
Soliz, C.10
Reyes, A.M.11
Vera, J.C.12
Rivas, C.I.13
-
52
-
-
57349113916
-
Mechanisms and regulation of vitamin C uptake: studies of the hSVCT systems in human liver epithelial cells
-
[52] Reidling, J.C., Subramanian, V.S., Dahhan, T., Sadat, M., Said, H.M., Mechanisms and regulation of vitamin C uptake: studies of the hSVCT systems in human liver epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 295:6 (2008), G1217–G1227.
-
(2008)
Am. J. Physiol. Gastrointest. Liver Physiol.
, vol.295
, Issue.6
, pp. G1217-G1227
-
-
Reidling, J.C.1
Subramanian, V.S.2
Dahhan, T.3
Sadat, M.4
Said, H.M.5
-
53
-
-
0030839797
-
Glucose transporter isoforms GLUT1 and GLUT3 transport dehydroascorbic acid
-
[53] Rumsey, S.C., Kwon, O., Xu, G.W., Burant, C.F., Simpson, I., Levine, M., Glucose transporter isoforms GLUT1 and GLUT3 transport dehydroascorbic acid. J. Biol. Chem. 272:30 (1997), 18982–18989.
-
(1997)
J. Biol. Chem.
, vol.272
, Issue.30
, pp. 18982-18989
-
-
Rumsey, S.C.1
Kwon, O.2
Xu, G.W.3
Burant, C.F.4
Simpson, I.5
Levine, M.6
-
54
-
-
84864886120
-
Classifying collective cancer cell invasion
-
[54] Friedl, P., Locker, J., Sahai, E., Segall, J.E., Classifying collective cancer cell invasion. Nat. Cell Biol. 14:8 (2012), 777–783.
-
(2012)
Nat. Cell Biol.
, vol.14
, Issue.8
, pp. 777-783
-
-
Friedl, P.1
Locker, J.2
Sahai, E.3
Segall, J.E.4
-
55
-
-
0033923661
-
Vitamin C status and mortality in US adults
-
[55] Loria, C.M., Klag, M.J., Caulfield, L.E., Whelton, P.K., Vitamin C status and mortality in US adults. Am. J. Clin. Nutr. 72:1 (2000), 139–145.
-
(2000)
Am. J. Clin. Nutr.
, vol.72
, Issue.1
, pp. 139-145
-
-
Loria, C.M.1
Klag, M.J.2
Caulfield, L.E.3
Whelton, P.K.4
-
56
-
-
84890110249
-
Serum antioxidant nutrients, vitamin A, and mortality in U.S adults
-
[56] Goyal, A., Terry, M.B., Siegel, A.B., Serum antioxidant nutrients, vitamin A, and mortality in U.S adults. Cancer Epidemiol. Biomarkers Prev. 22:12 (2013), 2202–2211.
-
(2013)
Cancer Epidemiol. Biomarkers Prev.
, vol.22
, Issue.12
, pp. 2202-2211
-
-
Goyal, A.1
Terry, M.B.2
Siegel, A.B.3
-
57
-
-
79955550511
-
4 Ascorbate exerts anti-proliferative effects through cell cycle inhibition and sensitizes tumor cells towards cytostatic drugs
-
[57] Fromberg, A., Gutsch, D., Schulze, D., Vollbracht, C., Weiss, G., Czubayko, F., Aigner, A., 4 Ascorbate exerts anti-proliferative effects through cell cycle inhibition and sensitizes tumor cells towards cytostatic drugs. Cancer Chemother. Pharmacol. 67:5 (2011), 1157–1166.
-
(2011)
Cancer Chemother. Pharmacol.
, vol.67
, Issue.5
, pp. 1157-1166
-
-
Fromberg, A.1
Gutsch, D.2
Schulze, D.3
Vollbracht, C.4
Weiss, G.5
Czubayko, F.6
Aigner, A.7
|